Common Contracts
2 similar Co-Development and License Agreement contracts
Co-development and License Agreement on NIP-022, a Novel Platelet Increasing AgentCo-Development and License Agreement • October 26th, 2015
Nissan Chemical Industries, Ltd. (Tokyo, Japan, President: Kojiro Kinoshita, “Nissan”) and Yakult Honsha Co., Ltd. (Tokyo, Japan, President: Takashige Negishi, “Yakult”) are pleased to announce that both companies have entered into a co-development and license agreement on NIP-022, a novel platelet increasing agent discovered by Nissan.
Co-development and License Agreement on NIP-022, a Novel Platelet Increasing AgentCo-Development and License Agreement • October 26th, 2015
Nissan Chemical Industries, Ltd. (Tokyo, Japan, President: Kojiro Kinoshita, “Nissan”) and Yakult Honsha Co., Ltd. (Tokyo, Japan, President: Takashige Negishi, “Yakult”) are pleased to announce that both companies have entered into a co-development and license agreement on NIP-022, a novel platelet increasing agent discovered by Nissan.
